Pharmaceutical stocks, including Pfizer (NYSE: PFE), have recently been scrutinized after President Trump’s executive order instructing drug manufacturers to reduce medicine prices to align with ...

CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump ...

Drugmakers Pfizer and Flynn Pharma have been ... so they were no longer subject to price regulations. Pfizer hiked the price of the drug between 780% and 1,600%, and also supplied the drug to ...

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

See More: Trump Reportedly Set To Accept ‘Flying Palace’ From Qatar, White House Says Lavish Gift Of Boeing Jumbo Jet Complies With ‘All Applicable Laws ... drug prices will be reduced ...

The health department has the most authority to change the prices of drugs covered by Medicare and Medicaid because it can set regulations ... Pharma giant Pfizer, which notched $63.6 billion ...

For example, the effects of drug pricing controls introduced by ... possibly Trump's stance on rolling back IRA regulations – suggests Pfizer will surprise the market with any outperformance ...